Large-scale testing (Phase 3)Study completedNCT06584916
What this trial is testing
Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
Who this might be right for
ObesityOverweight
Eli Lilly and Company 376